Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology

Background: Four previously reported studies have tested for association of blood proteins with neocortical amyloid-β burden (NAB). If shown to be robust, these proteins could have utility as a blood test for enrichment in clinical trials of Alzheimer’s disease (AD) therapeutics. Objective: This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Voyle, Nicola, Baker, David, Burnham, Samantha C., Covin, Antonia, Zhang, Zhanpan, Sangurdekar, Dipen P., Tan Hehir, Cristina A., Bazenet, Chantal, Lovestone, Simon, Kiddle, Steven, Dobson, Richard J.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923714/
https://www.ncbi.nlm.nih.gov/pubmed/25881911
http://dx.doi.org/10.3233/JAD-150020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923714/
https://www.ncbi.nlm.nih.gov/pubmed/25881911
http://dx.doi.org/10.3233/JAD-150020

Ejemplares similares